Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Generic topiramate is usually one of the lower-cost prescription options sometimes used off-label for weight loss, but the exact price depends on dose, pharmacy, insurance, and whether it is prescribed alone or as phentermine/topiramate extended-release. Topiramate alone is not FDA-approved for weight loss, so coverage can vary.
How much does topiramate cost for weight loss?
Topiramate cost is often lower than many branded weight-loss drugs because immediate-release topiramate is available as a generic. The exact amount can still change by 30-day or 90-day fill, tablet strength, pharmacy, coupon, and insurance rules.
Typical generic topiramate price ranges
Generic topiramate, the active ingredient in Topamax, is commonly priced as a lower-cost generic at retail pharmacies, but public discount prices are not fixed medical prices and can change by location and date 9. A prescriber may write topiramate for weight loss off-label, but topiramate’s FDA-approved labeling is for epilepsy and migraine prevention, not weight management 1.
Why pharmacy cash prices vary
Cash prices can vary because pharmacies buy from different wholesalers, apply different markups, and accept different discount programs. A person may also see different prices for immediate-release topiramate versus extended-release products such as Trokendi XR or Qudexy XR, which have their own FDA labeling for seizure and migraine indications 3.
How insurance, coupons, and dose affect cost
Insurance may cover topiramate when it is prescribed for an FDA-labeled use, such as seizure disorders or migraine prevention, but coverage for off-label weight-loss use may be limited by plan rules 1. Higher quantities, different strengths, prior authorization, and follow-up visits can all change the real out-of-pocket cost.
Is topiramate approved for weight loss?
Topiramate alone is not FDA-approved for weight loss. The FDA-approved topiramate-containing weight-loss option is phentermine/topiramate extended-release, sold under the brand name Qsymia, for chronic weight management in specific patients 2.
Topiramate vs Topamax
Topiramate is the generic active ingredient. Topamax is a brand name for topiramate, a generic antiepileptic medication used for certain seizure disorders and migraine prevention according to FDA labeling 1.
Why topiramate alone is considered off-label for weight loss
Off-label prescribing means a licensed clinician prescribes a medication for a use that is not in the FDA-approved label. Topiramate has been studied for weight loss in people with obesity, including a 24-week randomized trial by Bray and colleagues, but those study results do not make topiramate alone an FDA-approved weight-loss medication 5. Side effects in topiramate labeling include cognitive problems, mood symptoms, metabolic acidosis, kidney stones, and fetal risk during pregnancy 1.
How phentermine/topiramate extended-release differs
Qsymia combines phentermine and topiramate in an extended-release capsule. Its FDA label includes chronic weight management for adults with obesity, adults with overweight and at least one weight-related condition, and certain adolescents with obesity 2. The label also includes a boxed warning for embryo-fetal toxicity because topiramate exposure in pregnancy can increase the risk of oral clefts 2, 8.
What affects the price of topiramate?
Topiramate pricing is shaped by the drug form, quantity, pharmacy contract, and insurance rules. The lowest shelf price may not be the lowest total cost if side effects require extra visits, labs, pregnancy testing, or medication changes.
- Dose and tablet strength: Topiramate is sold in multiple strengths, and different strengths can have different pharmacy prices even when the active ingredient is the same 1.
- Immediate-release vs extended-release: Immediate-release generic topiramate is often less expensive than branded or extended-release topiramate products such as Trokendi XR or Qudexy XR, though exact costs vary 3, 9.
- Insurance formulary status: A plan may prefer one generic strength, require prior authorization, or deny coverage for off-label weight-loss use.
- Retail vs mail-order pharmacy: Some plans offer lower copays for 90-day mail-order fills, while discount-card prices may be better at certain retail pharmacies.
- Monitoring and related care: Topiramate labeling warns about metabolic acidosis, kidney stones, mood changes, cognitive effects, and pregnancy risk, which can add follow-up needs 1.
How does topiramate cost compare with other weight-loss medications?
Topiramate is often cheaper at the pharmacy counter than branded anti-obesity medicines, but it is not a stand-alone FDA-approved weight-loss drug. The best comparison is not just monthly cost; it is FDA status, evidence, side effects, contraindications, and follow-up burden.
Topiramate vs phentermine/topiramate
Topiramate alone is generic and off-label for weight loss. Phentermine/topiramate extended-release is FDA-approved for chronic weight management in specific patients, and in the CONQUER trial, Gadde and colleagues studied once-daily controlled-release phentermine/topiramate at 7.5 mg/46 mg and 15 mg/92 mg doses with weight loss outcomes over 56 weeks 4. Individual results vary, and Qsymia’s label includes important risks, including increased heart rate, mood and sleep disorders, cognitive impairment, metabolic acidosis, kidney stones, and embryo-fetal toxicity 2.
Topiramate vs GLP-1 medications
Semaglutide is a GLP-1 receptor agonist; Wegovy is the FDA-approved semaglutide brand for chronic weight management, and Ozempic is an FDA-approved semaglutide brand for type 2 diabetes with other labeled uses 6, 10. Tirzepatide is a dual GIP/GLP-1 receptor agonist; Zepbound is the FDA-approved tirzepatide brand for chronic weight management, and Mounjaro is an FDA-approved tirzepatide brand for type 2 diabetes 7, 11. GLP-1 and GIP/GLP-1 medications can cause nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis warnings, and have contraindications such as a personal or family history of medullary thyroid carcinoma or MEN2 in FDA labeling 10, 11.
Topiramate vs metformin and other lower-cost options
Metformin is a lower-cost generic diabetes medication that is sometimes discussed off-label in weight-related care, especially when insulin resistance or prediabetes is part of the picture. It is not FDA-approved as a weight-loss medication, and common adverse effects include gastrointestinal symptoms; rare but serious lactic acidosis is a boxed warning in labeling 12.
| Option | FDA status for weight loss | Typical cost factors | Key cautions |
|---|---|---|---|
| Topiramate, generic Topamax | Not FDA-approved alone for weight loss; approved for certain seizures and migraine prevention 1 | Usually generic; varies by strength, quantity, pharmacy, coupon, and insurance coverage 9 | Cognitive side effects, mood changes, metabolic acidosis, kidney stones, pregnancy-related fetal risk 1 |
| Phentermine/topiramate extended-release, Qsymia | FDA-approved for chronic weight management in specific adults and adolescents 2 | Brand pricing, coverage rules, prior authorization, monitoring needs | Embryo-fetal toxicity, heart rate increase, mood and sleep symptoms, cognitive effects, metabolic acidosis, kidney stones 2 |
| Semaglutide, GLP-1 receptor agonist; branded Wegovy or compounded semaglutide via 503A pharmacy | Wegovy is FDA-approved for chronic weight management; compounded semaglutide is not FDA-approved 10 | Brand coverage and supply rules, or cash-pay compounded plan when prescribed through a licensed provider | GI side effects, gallbladder disease, pancreatitis warning, thyroid C-cell tumor contraindication in labeling 10 |
| Tirzepatide, dual GIP/GLP-1 receptor agonist; branded Zepbound or compounded tirzepatide via 503A pharmacy | Zepbound is FDA-approved for chronic weight management; compounded tirzepatide is not FDA-approved 11 | Brand coverage and supply rules, or cash-pay compounded plan when prescribed through a licensed provider | GI side effects, gallbladder disease, pancreatitis warning, thyroid C-cell tumor contraindication in labeling 11 |
| Metformin | Not FDA-approved for weight loss; approved for type 2 diabetes 12 | Usually generic; varies by formulation, insurance, and pharmacy | GI side effects; rare lactic acidosis warning in labeling 12 |
What weight-loss medication options does Chia offer instead of topiramate?
Chia does not currently offer topiramate, Topamax, Trokendi XR, Qudexy XR, phentermine/topiramate extended-release, or Qsymia. For weight-loss care, we offer clinician-reviewed compounded semaglutide injection and compounded tirzepatide tablets or injection, with microdosing plans available when clinically appropriate. Compounded medications are not FDA-approved.
At Chia, treatment starts with a 100% online health questionnaire. A licensed US provider reviews your medical history, current medications, goals, and contraindications, then prescribes only if clinically appropriate; a prescription is never guaranteed.
Our compounded GLP-1 medications are compounded in the US by state-licensed 503A pharmacies and shipped to the patient’s door. Dosing is provider-guided and can be adjusted over time, including microdosing plans for semaglutide and tirzepatide where appropriate.
| Chia option | Forms Chia offers | Current starting price | Best fit to discuss with a provider |
|---|---|---|---|
| Semaglutide | Injection | Plans currently start at $249/mo | Patients who want a provider-guided GLP-1 receptor agonist path and are comfortable with injections |
| Tirzepatide | Tablets or injection | Tablets currently start at $249/mo; injection currently starts at $299/mo | Patients who want to discuss a dual GIP/GLP-1 option, including a non-injection tablet form when appropriate |
| Weight + Energy protocol | NAD+ injection plus choice of GLP-1 | Plans currently start at $309/mo | Patients who want to discuss weight care plus an energy-focused longevity protocol through Weight + Energy |
| Weight + Muscle protocol | Sermorelin injection plus choice of GLP-1 | Plans currently start at $329/mo | Patients who want to discuss GLP-1 care with a muscle-support-focused longevity protocol through Weight + Muscle |
3-min quiz
Compare clinician-reviewed weight-loss options
Chia does not prescribe topiramate or Qsymia. If you want to discuss options Chia does offer, you can review semaglutide injection, tirzepatide tablets or injection, or start an online eligibility review. A licensed provider must review your health history, and a prescription is not guaranteed. Compounded medications are not FDA-approved.
Can insurance cover topiramate for weight loss?
Insurance coverage for topiramate depends on why it is prescribed and how your plan handles off-label use. Because topiramate alone is not FDA-approved for weight loss, coverage for weight loss may be less predictable than coverage for labeled uses such as seizure disorders or migraine prevention 1.
- Ask whether your plan covers topiramate for the diagnosis on the prescription.
- Ask whether a prior authorization is needed.
- Ask whether the plan prefers a specific strength, quantity, or mail-order pharmacy.
- Ask your prescriber what follow-up, labs, pregnancy testing, or monitoring may be needed based on your risks.
- Ask the pharmacy to compare insurance copay pricing with available cash or discount pricing, since the lower option can vary.
If a clinician is considering Qsymia instead of generic topiramate, coverage rules may be different because Qsymia has an FDA weight-management indication, but it also has required safety steps related to pregnancy risk 2.
What side effects can change the real cost of topiramate?
Topiramate side effects can add cost through follow-up visits, lab checks, contraception counseling, pregnancy testing, or medication changes. A low monthly pill price is only one part of the decision.
Common side effects that may require follow-up
Topiramate labeling lists common adverse reactions such as paresthesia, fatigue, dizziness, somnolence, difficulty with memory, and difficulty with concentration or attention 1. These cognitive side effects matter for people who drive, study, operate machinery, or do work that requires sharp attention.
Cognitive, mood, kidney stone, and metabolic concerns
Topiramate can cause metabolic acidosis through carbonic anhydrase inhibition, and labeling warns that chronic metabolic acidosis may increase the risk of kidney stones and bone effects 1. Topiramate labeling also warns about suicidal behavior and ideation seen with antiepileptic drugs as a class 1.
Pregnancy and birth-defect warnings
Pregnancy risk is a major cost and safety issue. FDA safety communication and Qsymia labeling warn that topiramate exposure during pregnancy is associated with an increased risk of oral clefts, and Qsymia has a boxed warning for embryo-fetal toxicity 2, 8.
How can someone get a safe weight-loss medication plan?
A safe plan starts with a licensed clinician review, not just the cheapest medication. The right option depends on your medical history, pregnancy plans, medications, mental health history, kidney stone risk, diabetes status, and weight-related conditions.
- 1List your current medications and supplements, including seizure, migraine, mood, diabetes, and blood pressure medicines.
- 2Share pregnancy plans, contraception needs, or breastfeeding status before discussing topiramate or Qsymia because fetal risk changes the decision 2, 8.
- 3Ask what side effects should prompt follow-up, especially cognitive changes, mood symptoms, severe GI symptoms, kidney stone symptoms, or signs of dehydration.
- 4Ask how the medication will be monitored and how progress will be judged without assuming a guaranteed result.
- 5If you are considering a GLP-1 path through Chia, start with the online eligibility quiz so a licensed provider can review whether an option we offer is clinically appropriate.
For some patients, a clinician may discuss a GLP-1 receptor agonist, a dual GIP/GLP-1 receptor agonist, a non-GLP-1 option, or a combination approach. Human trials of semaglutide and tirzepatide show weight-loss effects for the active ingredients as studied, but individual results vary, side effects and contraindications matter, and outcomes are not established for compounded formulations 6, 7, 10, 11.
Who is this cost comparison best for?
This comparison is best for someone who is trying to understand low-cost weight-loss medication options before talking with a clinician. It is especially useful if you are comparing generic topiramate, Qsymia, and GLP-1 options over a monthly budget.
- It may help if you have been quoted a cash price for generic Topamax and want to understand why it differs from Qsymia.
- It may help if your insurer denied a weight-loss medication and you are comparing lower-cost prescriptions.
- It may help if you want to know why a clinician may focus on pregnancy risk, kidney stone history, mood history, or side effects before cost.
- It may help if you want a clinician-reviewed online path for GLP-1 options that Chia offers, while knowing Chia does not offer topiramate or Qsymia.
Generic topiramate is often one of the lower-cost prescription options at retail pharmacies, but the exact cash price depends on strength, quantity, pharmacy, location, and discounts 9. Always verify the current price with the pharmacy before filling.
No. Topiramate is one active ingredient. Qsymia is a brand-name extended-release capsule that combines phentermine and topiramate and is FDA-approved for chronic weight management in specific patients 2.
Topiramate has been studied for weight loss, and Qsymia is FDA-approved for chronic weight management in certain patients 2, 5. Topiramate alone is not FDA-approved for weight loss 1. Benefits must be weighed against side effects such as cognitive symptoms, mood changes, kidney stones, metabolic acidosis, and pregnancy risk 1, 2.
Not necessarily. They have different risks. Topiramate can affect thinking, mood, acid-base balance, kidney stone risk, and pregnancy safety 1, 2. GLP-1 medications can cause gastrointestinal side effects and have gallbladder, pancreatitis, and thyroid tumor warnings in labeling 10, 11. A clinician should compare risks for your health history.
Some licensed telehealth providers may prescribe topiramate online after a medical review, but it should not be obtained without a prescription. Chia does not currently offer topiramate, Topamax, Trokendi XR, Qudexy XR, or Qsymia.
No. Chia does not currently offer topiramate, Topamax, Trokendi XR, Qudexy XR, phentermine/topiramate extended-release, or Qsymia.
Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection, with microdosing plans available when clinically appropriate. Compounded medications are not FDA-approved, and a prescription requires licensed-provider review and is not guaranteed.
3-min quiz
Start with a clinician-reviewed plan
If you want to compare weight-loss options Chia offers, you can start an online visit for licensed-provider review. Chia does not offer topiramate or Qsymia, but we do offer compounded semaglutide injection and compounded tirzepatide tablets or injection when clinically appropriate. A prescription is never guaranteed. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health.
References
- 1.U.S. Food and Drug Administration. Topamax (topiramate) Prescribing Information. FDA, 2022.
- 2.U.S. Food and Drug Administration. Qsymia (phentermine and topiramate extended-release) Prescribing Information. FDA, 2022.
- 3.U.S. Food and Drug Administration. Trokendi XR (topiramate extended-release) Prescribing Information. FDA, 2023.
- 4.Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. The Lancet, 2011.
- 5.Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obesity Research, 2003.
- 6.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
- 7.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
- 8.U.S. Food and Drug Administration. FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate). FDA, 2011.
- 9.GoodRx. Topiramate Prices, Coupons and Patient Assistance Programs. GoodRx, 2026.
- 10.U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. FDA, 2024.
- 11.U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. FDA, 2024.
- 12.U.S. Food and Drug Administration. Glucophage (metformin hydrochloride) Prescribing Information. FDA, 2017.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



